Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5419627 | 0.85 | LMNA (0.45) | LMNA | |
| SCHEMBL5412526 | 0.85 | LMNA (0.45) | LMNA | |
| SCHEMBL19986527 | 0.82 | LMNA (0.30) | LMNA | |
| SCHEMBL5423906 | 0.82 | LMNA (0.41) | LMNA | |
| SCHEMBL3792627 | 0.82 | LMNA (0.50) | LMNA | |
| SCHEMBL399581 | 0.82 | LMNA (0.50) | LMNA | |
| SCHEMBL396922 | 0.82 | LMNA (0.50) | LMNA | |
| SCHEMBL20478198 | 0.82 | LMNA (0.50) | LMNA | |
| SCHEMBL20478196 | 0.82 | LMNA (0.50) | LMNA | |
| SCHEMBL3741069 | 0.82 | LMNA (0.50) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10040923-B2 | Room-temperature-curable organopolysiloxane composition, and moulded product comprising cured product of said room-temperature-curable organopolysiloxane composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-08-07 | — | — | US | disclosed |
| US-20170130031-A1 | ROOM-TEMPERATURE-CURABLE ORGANOPOLYSILOXANE COMPOSITION, AND MOULDED PRODUCT COMPRISING CURED PRODUCT OF SAID ROOM-TEMPERATURE-CURABLE ORGANOPOLYSILOXANE COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-05-11 | — | — | US | disclosed |
| US-20170037066-A1 | NOVEL BIS (ALKOXYSILYL-VINYLENE) GROUP-CONTAINING SILICON COMPOUND AND PRODUCTION METHOD OF SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-02-09 | — | — | US | disclosed |
| US-20150159039-A1 | RADIATION CURABLE COMPOSITION, AND METHOD FOR PREPARING A HYBRID SOL-GEL LAYER ON A SURFACE OF A SUBSTRATE USING SAID COMPOSITION | SOCOMORE (FR) | 2015-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170037066-A1 | NOVEL BIS (ALKOXYSILYL-VINYLENE) GROUP-CONTAINING SILICON COMPOUND AND PRODUCTION METHOD OF SAME | ACVRL1, MSL1, HBS1L | LMNA 2309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.